Last reviewed: June 7, 2026 Last updated: June 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
In the pancreas, semaglutide enhances glucose-dependent insulin secretion, meaning it only triggers insulin release when blood sugar is elevated
This includes stimulating insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting a sense of fullness, all of which contribute to its efficacy in managing obesity and type 2 diabetes
Is the Retatrutide ruined